What is NXGLW's health score?

NEXGEL, INC. (NXGLW) has a TradeApes health score of 50 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NXGLW's estimated fair value?

Based on our 5-year discounted cash flow model, NEXGEL, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NXGLW undervalued or overvalued?

Our model currently rates NXGLW as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for NXGLW... Refresh in a moment for the full analysis.

NEXGEL, INC. (NXGLW)

Healthcare Fair Value High mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

55 Mixed

Operating Trend

65 Healthy

Relative Value

40 Weak

Capital Allocation

40 Weak

Risk

35 Weak

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.